搜索结果

Search Results for " sars-cov-2-in-11 "

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T40341	SARS-CoV-2-IN-11
	SARS-CoV-2-IN-11 is a highly potent and non-toxic inhibitor of the 3C-like protease (3CLpro) of SARS-CoV-2, demonstrating IC50 and EC50 values of 0.17 nM and 1.45 nM, respectively. This compound targets the essential viral replication enzyme, 3CLpro, making it an attractive candidate for intervention strategies. SARS-CoV-2-IN-11 holds significant promise in the development of specific antivirals against SARS-CoV-2.
T72313	SARS-CoV-2 3CLpro-IN-11
	SARS-CoV-2 3CLpro-IN-11(11d)为一种针对SARS-CoV-2 3CL蛋白酶的有效抑制剂，具备IC50值140 nM，并对SARS-CoV-1和MERS-CoV分别展现出IC50值240 nM与70 nM的抑制活性，显示出其广谱的抗病毒能力。
T60818	SARS-CoV-2-IN-15
	SARS-CoV-2-IN-15 (compound 11) 是一种氯硝柳胺类似物，其在人血浆和肝 S9 酶测定中比氯硝柳胺具有更高的稳定性。当口服给药时，它可以提高生物利用度和半衰期。SARS-CoV-2-IN-15 是SARS-CoV-2的有效抑制剂，IC50值为 0.49 μM。
T71191	Covidcil-19
	Covidcil-19 binds to the revised attenuator hairpin structure of the SARS-CoV-2 frameshifting element (FSE) with high affinity (Kd = 11 nM). It stabilizes the hairpin's folded state and reduces frameshifting efficiency in cells. Covidcil-19 inhibits viral propagation and reduces viral infectivity by > 3.5 orders of magnitude.
T76849	Bamlanivimab
	Bamlanivimab (Anti-Human SARS-CoV-2) 是一种针对COVID-19的单克隆抗体(mAb)，于2020年11月获得美国食品药品监督管理局(FDA)的紧急使用授权(EUA)。然而，由于SARS-CoV-2病毒耐药性变体的增多，该授权于2021年4月被撤销。
T38174	Mpro inhibitor N3 hemihydrate
	Mpro inhibitor N3 hemihydrate is a potent inhibitor of SARS-CoV-2 Mpro with an EC50 of 16.77 μM for SARS-CoV-2. Mpro inhibitor N3 hemihydrate specifically inhibits Mpro from multiple coronaviruses, including SARS-CoV and MERS-CoV. Mpro inhibitor N3 hemihydrate displays inhibition against HCoV-229E, FIPV, and MHV-A59 with individual IC50 of 4.0 μM, 8.8 μM, and 2.7 μM, respectively[1][2]. Mpro inhibitor N3 hemihydrate (0-0.64 μM) is able to penetrate cells to inhibit the replication of IBV viruses...